Arctic Bioscience AS
F:9TD
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Intrinsic Value
The intrinsic value of Arctic Bioscience AS (9TD) under the Base Case is EUR per share. Compared with the current market price of 0.214 EUR, the stock appears .
The intrinsic value is calculated using the DCF method.
Do our valuations actually work? See backtest results .
What one share is worth in the bear, base and bull cases.
Create a free account · No card needed
Do our valuations actually work? See backtest results .
Intrinsic value next to the price over the past 5 years, and what happened after valuations like today’s.
Create a free account · No card needed
Fundamental Analysis
What Arctic Bioscience AS Does
Arctic Bioscience AS engages in the development, manufacturing, and marketing of marine ingredients extracted from herring roe. The company is headquartered in Orsta, More Og Romsdal. The company went IPO on 2021-02-24. Arctic Bioscience’s purpose is to provide people with autoimmune disorders an effective and healthy therapy based on marine membrane lipids. The firm is developing HRO350 - a novel investigational drug candidate.
- Headquarters
- Norway NO
- IPO date
- Feb 24, 2021
Earnings Waterfall
Arctic Bioscience AS
What is the Intrinsic Value of one 9TD stock?
The intrinsic value for Arctic Bioscience AS (9TD) under the Base Case is EUR.
Is 9TD stock undervalued or overvalued?
Compared with the current market price of 0.214 EUR, the stock appears .